ANVISA-2020-0025-V325

Minor variation for application ANVISA-2020-0025. Minor variation: Analytical Method Change for Tisagenlecleux-B — minor update

Variation Number
ANVISA-2020-0025-V325
Type
Minor
Application
ANVISA-2020-0025
Change
CHG-2024-0025
Status
Draft
Fee
€1,302
Submitted
2023-10-17
Approved
—
Description

Minor variation: Analytical Method Change for Tisagenlecleux-B — minor update